Drug targeting in cancer therapy

PDF
Published: Mar 19, 2020
DOI: https://doi.org/10.12681/osj.22596
Keywords:
thermodox doxorubicin nano capsules liposomes chemotherapy radio frequency ablation
L. Nys
Gymnasium dew Kreuzschwestern
P. Raeuschl
Gymnasium der Kreuzschwetstern
S. Ess
Dept. Biosciences, University of Salzburg
R. Nestelbacher
Dept. Biosciences, University of Salzburg
I.A. Joubert
Dept. Biosciences, University of Salzburg
Μ. Geppert
M. Himly
Abstract
Drug targeting enables the local reslease of medication at the desired site or organ. This ensures that the drug asserts its effects focused to a small site, minimising systematic side effects. Drug targeting has been successfully applied in cancer therapy and can be performed actively or passively. During passive drug targeting, carriers containing the active cancer drug concentrate within the tumour tissue due to increased blood circulation and vascular permeation (enhanced penetration retention principle). Active drug targeting on the other hand, facilitates ligand-recepto interacions.
Article Details
  • Section
  • Austria
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to a repository), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Downloads
Download data is not yet available.
Author Biography
M. Himly
Dept. Biosciences, University of Salzburg
Most read articles by the same author(s)